Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7292
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies ; day:31 ; month:5 ; year:2021 ; pages:1-9
Familial cancer ; (31.5.2021), 1-9
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10689-021-00263-z
- URN
-
urn:nbn:de:101:1-2021092519002652007307
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schlegelberger, Brigitte
- Mecucci, Cristina
- Wlodarski, Marcin
- SpringerLink (Online service)
Other Objects (12)
Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
Targeting splicing for hematological malignancies therapy
Genomic testing for germline predisposition to hematologic malignancies
Advances in nano-immunotherapy for hematological malignancies
Deubiquitinases in hematological malignancies
Histone deacetylase inhibitors: clinical implications for hematological malignancies
BCL-2 as therapeutic target for hematological malignancies
Syk inhibitors in clinical development for hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
Targeting splicing for hematological malignancies therapy
Genomic testing for germline predisposition to hematologic malignancies
Advances in nano-immunotherapy for hematological malignancies
Deubiquitinases in hematological malignancies
Histone deacetylase inhibitors: clinical implications for hematological malignancies
BCL-2 as therapeutic target for hematological malignancies
Syk inhibitors in clinical development for hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
Targeting splicing for hematological malignancies therapy
Genomic testing for germline predisposition to hematologic malignancies
Advances in nano-immunotherapy for hematological malignancies
Deubiquitinases in hematological malignancies
Histone deacetylase inhibitors: clinical implications for hematological malignancies
BCL-2 as therapeutic target for hematological malignancies
Syk inhibitors in clinical development for hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies